|Bid||0.5400 x 0|
|Ask||0.5600 x 0|
|Day's Range||0.5300 - 0.5600|
|52 Week Range||0.2500 - 1.0800|
|Beta (3Y Monthly)||1.41|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to provide an update on its premium cannabis brand for the recreational market, CALIBER, as it plans to launch premium cannabis oil products utilizing its BioNatural Oil (“BNO”), a unique and differentiated cannabis oil produced by Sproutly’s proprietary Aqueous Phytorecovery Process (“APP Technology”). Sproutly intends to expand the CALIBER brand of products initially into oil capsules, which will be packaged in child resistant, 30 capsule jars. BNO is recovered using the Company’s proprietary APP Technology.
Sproutly Canada, Inc. (SPR.CN) (38G.F) (SRUTF) (“Sproutly" or the “Company”) today announced the Company’s financial results for the year ended February 28, 2019. After going public in July of 2018, we acquired Infusion Biosciences Canada and SSM partners, providing us with access to their ground-breaking APP technology to produce water-soluble cannabinoids (“Infuz2O”) and oil-based cannabinoids (“Bio Natural Oil”) which provides the Company with a differentiating proprietary technology to compete in the infused beverage and edible category. In 2019 we also completed our GTA production facility, received our cultivation license from Health Canada and began full-scale production of all 13 grow rooms” said Keith Dolo, Chief Executive Officer of Sproutly.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to announce that it has successfully completed the first run of the proprietary Aqueous Phytorecovery Process (“APP”) extraction technology licensed from Infusion Biosciences Inc. at its wholly-owned Toronto Herbal Remedies Inc. (“THR”) licensed facility. This initial APP run successfully recovered both water-soluble cannabinoids (“Infuz2O”), with onset of effects within approximately 5 minutes and which dissipate within approximately 90 minutes, and oil-based cannabinoids (“Bio Natural Oil”), a strain specific cannabis oil. The initial Infuz2O and Bio Natural Oil recovered is expected to be used for R&D and product formulation purposes for cannabis beverages and edibles within the proposed regulations recently announced by Health Canada.
“Recognizing our first commercial sale to another, well recognized, licensed producer is a milestone that we are very proud of. This shipment marks the beginning of Sproutly’s revenue stream and demonstrates our teams ability to, once again, deliver on our strategy.” - said Keith Dolo, Chief Executive Officer, Sproutly Canada. “As Sproutly awaits our Health Canada inspection to achieve our sales license, we may consider selling more wholesale, high quality craft flower, to ensure a consistent inflow of revenue over the coming months.” – states Dolo. Following the receipt of its sales license from Health Canada, Sproutly plans to sell THR’s premium cannabis flower under the CALIBER brand. CALIBER is designed for the cannabis connoisseur and delivered via Sproutly’s craft cannabis flower production. With high-quality manufacturing process, award-winning genetics and distinct premium packaging, the CALIBER brand is expected to deliver a superior cannabis experience for the cannabis connoisseur.
Sproutly Canada, Inc. (CSE:SPR) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to announce that through its wholly owned subsidiary Toronto Herbal Remedies Inc (“THR”), has submitted an amendment for a sales license for cannabis flower. THR has successfully completed its first packaging run for cannabis flower product and has provided all supporting documents to Health Canada. Following a “compliant” rating after their last inspection earlier this year, THR is now looking forward to their next visit from Health Canada in anticipation of receipt of their sales license.
Delta and Kelowna, British Columbia--(Newsfile Corp. - June 4, 2019) - Investorideas.com, a global news source covering leading sectors including cannabis and its potcast site, www.potcasts.ca release today's special edition of Investorideas.com potcastsCM, featuring an interview with Dr. Arup Sen, the Chief Science Officer for Sproutly Canada Inc. (CSE: SPR) (OTCQB: SRUTF). Dr. Sen discusses Sproutly's recent developments and how they are approaching the Canadian cannabis beverages market expected to open up this ...
Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YORK , May 17, 2019 /PRNewswire/ -- Virtual Investor Conferences, ...
Sproutly Canada, Inc. (CSE:SPR) (SRUTF) (38G.F) (“Sproutly" or the “Company”) is pleased to provide an update on its premium cannabis brand for the recreational market, CALIBER. CALIBER is designed for the cannabis connoisseur and delivered via Sproutly’s craft cannabis flower production. “Sproutly has made significant progress towards the launch of CALIBER, our premium cannabis brand for the recreational market.” said Melise Panetta, Vice President Marketing and Sales.
NEW YORK, May 13, 2019 -- Wall Street Reporter, the trusted name in financial news since 1843, has recently published interviews with CEO’s of some of today’s most talked.
Chief Executive Officer (“CEO”), Keith Dolo, will present at the Canaccord Genuity 3rd annual cannabis conference on May 14th at the Grand Hyatt in New York. CEO Keith Dolo will present as the Cannastocks2019 Q1 investor conference on May 15th, also in New York. Chief Science Officer (“CSO”), Arup Sen, will present at the Cannabis Drinks Expo at the South San Francisco Conference Center in San Francisco on July 25th.
Poised to capture an outsized share of the infused beverage boom, Sproutly Canada Inc. (SRUTF) (CSE:SPR) and Moosehead announced a joint venture that marries Moosehead’s vast adult-beverage experience with Sproutly’s innovative cannabis technology. Moosehead is an iconic Canadian brand, selling more than 140 million bottles of beer annually across Canada, the U.S. and 15 countries around the world. The company’s 152 years of beverage experience and formulation prowess has led to over a dozen popular brands, including licensed and supporting partner brands such as Angry Orchard, Twisted Tea and Samuel Adams beer, proving the ability to manufacture and market leading adult beverages.
NEW YORK, May 02, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsWire – Sproutly Canada Inc. (SRUTF) (CSE:SPR) today announces its placement in an editorial published by CannabisNewsWire ("CNW"), a multifaceted financial news and publishing company for private and public entities in the cannabis industry. At that time, consensus was that Canada could reach CA$2.8 billion in legal sales by 2020. Joining the ranks of the majors to meet this titanic demand, Sproutly Canada Inc. (SRUTF) (CSE:SPR) announced a joint venture with Moosehead Breweries, the largest and oldest independent beer company in Canada.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”), will be hosting a conference call with Keith Dolo, CEO of Sproutly, Dr. Arup Sen, Chief Science Officer of Sproutly, and Matthew Oland, Moosehead Breweries Limited executive and incoming CEO of the Joint Venture (defined below), at 9:30am Eastern Time on May 1st, 2019. The purpose of the call will be to discuss the recently announced definitive agreement with OCC Holdings Ltd., an affiliate of Moosehead Breweries Limited (“Moosehead”), to form an exclusive joint venture (the “Joint Venture”). A presentation related to the Joint Venture is available on Sproutly’s website www.sproutly.ca as well as at the download link below.
Point Roberts, Washington D.C. and Delta, British Columbia--(Newsfile Corp. - April 30, 2019) - Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot featuring Sproutly Canada, Inc. (CSE: SPR) (OTCQB: SRUTF), looking at cannabis-infused beer JV's and distribution partnerships as they ready themselves for the upcoming Canadian consumables market, as regulations are expected to permit this October. The attention surrounding cannabis-infused beers is bringing in new players such ...
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”), and OCC Holdings Ltd., an affiliate of Moosehead Breweries Limited (“Moosehead”), are pleased to announce that they have entered into a definitive agreement (the “Joint Venture Agreement”) to form an exclusive joint venture (the “Joint Venture” or the “JV”) to develop, produce, and market non‐alcoholic cannabis-infused beverages in Canada using Sproutly’s proprietary, naturally produced water soluble cannabinoids known as ‘Infuz2O’. Both companies will bring their respective strengths to the joint venture to develop a line of great tasting cannabis beverages featuring a rapid onset and offset effect unique to the category.
Sproutly Canada, Inc. (SPR.CN) (SRUTF) (38G.F) (“Sproutly" or the “Company”), is pleased to announce that the Company’s wholly-owned subsidiary, Toronto Herbal Remedies Inc. (“THR”), a licensed producer under the Cannabis Act, has received a processing licence from Health Canada effective March 29, 2019 (the “Processing License”). The Processing License allows THR to produce cannabis oil and related products, and will also allow the Company to conduct certain research and development activities, including the formulation of proprietary beverage products. “We are making steady progress towards achieving Sproutly’s mission of delivering a safe and consistent whole plant experience from cannabis, with a lead position in the beverage market.
Investorideas.com, a leading investor news resource covering hemp and cannabis stocks releases a snapshot looking at the CBD and cannabis infused beverage sector and how companies are preparing to enter this new market segment. In recent news, Food and Drug Administration Commissioner Scott Gottlieb said his agency has plans to regulate CBD edibles and will start holding public hearings on the matter as early as April. Since the legalization of hemp and hemp-derived CBD in the Farm Bill, the CBD industry has eyed the FDA's position toward the substance, as it represents an obstacle to mass-market CBD edibles from a federal standpoint.